只使用免费官方源:SEC Forms 3/4/5 结构化内部人申报,以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界,不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量;个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S(公开市场或私下交易),成交金额由股数 × 每股价格计算。
官方数据说明| 2026-06-24 2026-06-26 | PRAX Praxis Precision Medicines, Inc. | DeSimone Jill Director | 卖出(S) | 837 | US$315.71 | US$264,249.27 | 2,337 | SEC |
| 2026-06-24 2026-06-26 | PRAX Praxis Precision Medicines, Inc. | DeSimone Jill Director | 卖出(S) | 504 | US$313.66 | US$158,084.64 | 4,453 | SEC |
| 2026-06-24 2026-06-26 | PRAX Praxis Precision Medicines, Inc. | DeSimone Jill Director | 卖出(S) | 1,004 | US$312.83 | US$314,081.32 | 4,957 | SEC |
| 2026-06-24 2026-06-26 | PRAX Praxis Precision Medicines, Inc. | DeSimone Jill Director | 卖出(S) | 2,854 | US$311.91 | US$890,191.14 | 5,961 | SEC |
| 2026-06-24 2026-06-26 | PRAX Praxis Precision Medicines, Inc. | DeSimone Jill Director | 卖出(S) | 1,750 | US$310.89 | US$544,057.50 | 8,815 | SEC |
| 2026-06-24 2026-06-26 | PRAX Praxis Precision Medicines, Inc. | DeSimone Jill Director | 卖出(S) | 999 | US$309.38 | US$309,070.62 | 10,565 | SEC |
| 2026-06-24 2026-06-26 | PRAX Praxis Precision Medicines, Inc. | DeSimone Jill Director | 卖出(S) | 1,240 | US$308.24 | US$382,217.60 | 11,564 | SEC |
| 2026-06-24 2026-06-26 | PRAX Praxis Precision Medicines, Inc. | DeSimone Jill Director | 卖出(S) | 683 | US$306.77 | US$209,523.91 | 12,804 | SEC |
| 2026-06-24 2026-06-26 | PRAX Praxis Precision Medicines, Inc. | DeSimone Jill Director | 卖出(S) | 320 | US$305.31 | US$97,699.20 | 13,487 | SEC |
| 2026-06-24 2026-06-26 | PRAX Praxis Precision Medicines, Inc. | DeSimone Jill Director | 卖出(S) | 120 | US$303.13 | US$36,375.60 | 13,807 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| PRAX | 157,736.2401 | 0 | 182,924.6197 | 86.23% | B, Q, N |